Characterization of ion channels involved in the proliferative response of femoral artery smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 6, 2010, Pages 1203-1211

  Cidad, Pilar ^a   Moreno Domínguez, Alejandro ^a   Novensá, Laura ^b   Roqué, Mercé ^b   Barquín, Leire ^b   Heras, Magda ^b   Pérez García, M Teresa ^a   López López, José R ^a  

^a Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Gene expression; Ion channels; Kv1.3 channels; Restenosis; Vascular biology; Vascular muscle; Vascular remodeling

Indexed keywords

ION CHANNEL; MESSENGER RNA; POTASSIUM CHANNEL KV BETA 2; POTASSIUM CHANNEL KV1.3; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL FUNCTION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; EXPERIMENTAL MODEL; EXPLANT; FEMORAL ARTERY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENE EXPRESSION PROFILING; GENOTYPE; HYPERPLASIA; KV1.3 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; POTASSIUM CHANNEL BLOCKERS; RNA, MESSENGER; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; UP-REGULATION; VASOCONSTRICTION;

EID: 77952886656     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.205187     Document Type: Article

References (33)

1. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
2. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998;18:333-338.
3. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res. 2006;98:868-878.
4. Neylon CB. Potassium channels and vascular proliferation. Vasc Pharmacol. 2002;38:35-41.
5. Beech DJ. Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans. 2007;035: 890-894.
6. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC, Haller H. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J. 1998;12:593-601.
7. Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P, Naylor J, Forte A, Cipollaro M, McHugh D, Kingston PA, Heagerty AM, Munsch CM, Bergdahl A, Hultgardh-Nilsson A, Gomez MF, Porter KE, Hell-strand P, Beech DJ. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res. 2006;98: 557-563.
8. Miguel-Velado E, Moreno-Dominguez A, Colinas O, Cidad P, Heras M, Perez-Garcia MT, Lopez-Lopez JR. Contribution of Kv channels to phenotypic remodeling of human uterine artery smooth muscle cells. Circ Res. 2005;97:1280-1287.
9. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, Grgic I, Kampfe D, Si H, Wibawa J, Real R, Borner K, Brakemeier S, Orzechowski HD, Reusch HP, Paul M, Chandy KG, Hoyer J. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation. 2003;108: 1119-1125.
10. Tharp DL, Bowles DK. The intermediate-conductance Ca2+-activated K+ channel (KCa3.1) in vascular disease. Cardiovasc Hematol Agents Med Chem. 2009;7:1-11
11. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20: 335-342.
12. Moreno-Dominguez A, Cidad P, Miguel-Velado E, Lopez-Lopez JR, Perez-Garcia MT. De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain. J Physiol. 2009;587:625-640.
13. -AACt method. Methods. 2001;25: 402-408.
14. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
15. Gusnanto A, Calza S, Pawitan Y. Identification of differentially expressed genes and false discovery rate in microarray studies. Curr Opin Lipidol. 2007;18:187-193.
16. + channels in rat mesenteric arterial cells. Eur J Pharmacol. 1999;372:103-107.
17. Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, LeeHealey CJ, Andrews S, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, Knaus HG, Nepom GT, Gutman GA, Calabresi PA, Chandy KG. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA. 2006;103:17414-17419.
18. Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hansel W, Wulff H. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol. 2005;68:1254-1270. (Pubitemid 41539982)
19. Jackson WF. Ion Channels and Vascular Tone. Hypertension. 2000; 35:173.
20. Michelakis ED, Reeve HL, Huang JM, Tolarova S, Nelson DP, Weir EK, Archer SL. Potassium channel diversity in vascular smooth muscle cells. Can J Physiol Pharmacol. 1997;75:889-897.
21. Smith PD, Brett SE, Luykenaar KD, Sandow SL, Marrelli SP, Vigmond EJ, Welsh DG. KIR channels function as electrical amplifiers in rat vascular smooth muscle. J Physiol. 2008;586:1147-1160.
22. + channels in smooth muscle. J Physiol. 2006;572:617-624.
23. Fountain SJ, Cheong A, Flemming R, Mair L, Sivaprasadarao A, Beech DJ. Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle. J Physiol. 2004;556:29-42.
24. Jackson WF. Potassium channels in the peripheral microcirculation. Microcirculation. 2005;12:113-127.
25. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res. 2004;68:75-103.
26. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch. 2008;456:769-785.
27. Long X, Tharp DL, Georger MA, Slivano OJ, Lee MY, Wamhoff BR, Bowles DK, Miano JM. The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem. 2009;284:33671-33682.
28. + channel complexes. J Neurosci. 1997;17:8246-8258.
29. + channel Kv1.3. J Biol Chem. 1999;274:20123-20126.
30. Miguel-Velado E, Perez-Carretero FD, Colinas O, Cidad P, Heras M, Lopez-Lopez JR, Perez-Garcia MT. Cell-cycle dependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells. Cardiovasc Res. 2010, cvq011.
31. Erdogan A, Schaefer CA, Schaefer M, Luedders DW, Stockhausen F, Abdallah Y, Schaefer C, Most AK, Tillmanns H, Piper HM, Kuhlmann CR. Margatoxin inhibits VEGF-induced hyperpolarization, proliferation and nitric oxide production of human endothelial cells. J Vasc Res. 2005;42:368-376.
32. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology. 2004;19:285-292.
33. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;8:982-1001.